Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
64.97 USD | +0.02% | +0.05% | +240.87% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.87% | 4.46B | |
+9.78% | 115B | |
+11.91% | 106B | |
-2.74% | 21.96B | |
-13.96% | 21.87B | |
-5.29% | 19.21B | |
-3.02% | 18.08B | |
-38.57% | 17.71B | |
+6.41% | 14.32B | |
+35.11% | 12.42B |
- Stock Market
- Equities
- ALPN Stock
- News Alpine Immune Sciences, Inc.
- Wolfe Research Downgrades Alpine Immune Sciences to Peer Perform From Outperform